1. Home
  2. VIVS vs BRTX Comparison

VIVS vs BRTX Comparison

Compare VIVS & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$0.20

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

SELL

Current Price

$2.28

Market Cap

3.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VIVS
BRTX
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.1M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
VIVS
BRTX
Price
$0.20
$2.28
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $160.00
AVG Volume (30 Days)
★ 587.7K
25.1K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $4,603,000.00
$81,000.00
Revenue This Year
$228,144.28
$290.60
Revenue Next Year
N/A
$64.59
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 8.82
N/A
52 Week Low
$0.19
$0.14
52 Week High
$3.54
$4.10

Technical Indicators

Market Signals
Indicator
VIVS
BRTX
Relative Strength Index (RSI) 28.24 54.32
Support Level N/A $0.22
Resistance Level $0.30 $2.93
Average True Range (ATR) 0.02 0.20
MACD 0.00 -0.11
Stochastic Oscillator 16.30 26.15

Price Performance

Historical Comparison
VIVS
BRTX

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: